AbbVie"s HCV Drug Mavyret Succeeds in Label Expansion Study

Zacks.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) read more.....»»

Pacira's (PCRX) phase IV study of its lead drug Exparel in patients underg.....»»

AbbVie's Upadacitinib outperforms dupilumab in Phase 3b/4 study for atopic dermatitis treatment, achieving superior efficacy and rapid skin clearance than Dupixent. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) read more.....»»

Analysts had high hopes for the label expansion, with Stifel expecting the approval to bring in more than $100 million in revenue for Acadia in 2022. A trader reacts during the opening bell at the New York Stock Exchange (NYSE) on F.....»»

Clovis Oncology Inc (NASDAQ: CLVS) shares are advancing strongly after the company clinched a regulatory milestone with respect to its oncology drug Rubraca. 0 read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) Dova Pharmaceuticals.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) read more.....»»

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 25.) Coherus Biosciences Inc (NASDAQ: CHRS) read more.....»»

The following is a roundup of top developments in the biotech space .....»»

Pfizer's (PFE) Eucrisa ointment is found safe in a late-stage label expansion study for treating mild to moderate atopic dermatitis .....»»

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced Friday that the Food and Drug Administration approved a label expansion for the drug Emflaza to include younger patients with Duchenne muscular dystrophy who are between 2 and 5 years old.  read more.....»»

Amarin's (AMRN) label expansion application for hypertriglyceridemia drug, Va.....»»

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)'s cannabidiol drug Epidiolex is inching closer to another FDA approval.  What Happened GW Pharma reported Monday after the close w.....»»

Although sales of Clovis' (CLVS) Rubraca improved in the fourth quarter of 2018, the drug may face significant competition going forward. Clovis is also evaluating .....»»

Zacks.....»»

Jazz Pharmaceuticals (JAZZ) announced positive top-line data from its phase III study on low sodium formulation of Xyrem, JZP.....»»

The FDA approves a label expansion of Regeneron's (REGN) asthma drug, Dupixent for moderate-to-severe atopic dermat.....»»

Shares of Pacira (PCRX) jump by about 12.9% after its drug Exparel gets app.....»»